Home Newsfeeds Novartis Earlier Launched New $11B Share Buyback Program

Novartis Earlier Launched New $11B Share Buyback Program

-Reuters https://www.reuters.com/business/healthcare-pharmaceuticals/novartis-launches-new-share-buyback-up-10-its-stock-2023-03-13/

byCharles Gross

March 13, 2023

1 minute read

-Reuters

https://www.reuters.com/business/healthcare-pharmaceuticals/novartis-launches-new-share-buyback-up-10-its-stock-2023-03-13/

Needham Maintains Buy on Montrose Environmental Gr, Lowers Price Target to $60

By Benzinga Newsdesk

August 10, 5:42 AM

Needham analyst James Ricchiuti maintains Montrose Environmental Gr (NYSE:MEG) with a Buy and lowers the price target from $65 to $60.

MEG

Vistagen Announces European Patent Office Intention To Grant New PH80 Nasal Spray Patent For The Treatment Of Migraine

By Benzinga Newsdesk

June 13, 8:04 AM

Vistagen (NASDAQ:VTGN), a late clinical-stage biopharmaceutical company aiming to transform the treatment landscape for individuals living with anxiety, depression, and other central nervous system (CNS) disorders, today

VTGN

Huntington Bancshares Likely To Report Lower Q3 Earnings; Here’s A Look At Recent Price Target Changes By The Most Accurate Analysts

By Lisa Levin

October 20, 3:37 AM

Huntington Bancshares Incorporated (NASDAQ: HBAN) is expected to release financial results for its third quarter, before the opening bell on Oct. 20, 2023.

HBAN

Legal
News

Cal-Maine Foods, Inc. Issues Statement On Recent Court Decision; Says “Cal-Maine Foods Will Vigorously Contest Plaintiffs’ Presentation Of Purported Damages And Will Continue To Assess The Decision And Options For Appeal”

By Benzinga Newsdesk

November 22, 10:46 AM

Cal-Maine Foods, Inc. (NASDAQ:CALM) ("Cal-Maine Foods" or the "Company"), the largest producer and distributor of fresh shell eggs in the United States, today issued the following statement:Approximately 20 years ago,

CALM

Novartis Earlier Launched New $11B Share Buyback Program

Related Posts

Needham Maintains Buy on Montrose Environmental Gr, Lowers Price Target to $60

Vistagen Announces European Patent Office Intention To Grant New PH80 Nasal Spray Patent For The Treatment Of Migraine

Huntington Bancshares Likely To Report Lower Q3 Earnings; Here’s A Look At Recent Price Target Changes By The Most Accurate Analysts

Cal-Maine Foods, Inc. Issues Statement On Recent Court Decision; Says “Cal-Maine Foods Will Vigorously Contest Plaintiffs’ Presentation Of Purported Damages And Will Continue To Assess The Decision And Options For Appeal”